Celestial Biolabs launches ‘Cadalmin Gae’ to treat arthritis

10 Jul 2014 Evaluate

Celestial Biolabs has launched ‘Cadalmin Gae’, a marine derived, developed, formulated clinically tested and patented natural product to treat arthritis (all kinds of joint pain). The product has received remarkable response from doctors as well as patients. The product is very effective, safe and vegetarian. The product is quite affordable as the selling price of the product is 1/3rd of the chemically derived medicine available in the market being used for arthritis.

In order to reach to all the affected people suffering with arthritis, the company is planning to take this product to OTC route of marketing so that majority of the people affected with joints pain can be benefitted.

Celestial Biolabs (CBL) has been supporting Pharma, Bio-pharma and Biotech manufacturing with customized ITsolutions and contract research. CBL also involved in the R&D, commercial production and marketing of enzymes, nutraceuticals. Celestial Biolabs is setting up a biotechnology facility in Genome Valley at Hyderabad, India to manufacture its own drug molecules, industrial enzymes and to contract research activities.

Celestial Biolabs Share Price

2.43 0.00 (0.00%)
11-Mar-2020 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1519.25
Dr. Reddys Lab 6111.50
Cipla 1538.90
Zydus Lifesciences 1082.80
Lupin 1635.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.